晚发性母乳性黄疸126例临床治疗分析  

Analysis of Treatment for 126 cases of Late-onset Breast-feeding Jaundice

作　　者：李雅丹 吕美丽 林新祝 林雅茵 

机构地区：[1]厦门市妇幼保健院新生儿科,福建厦门361003 [2]哈尔滨市龙博门诊部,黑龙江哈尔滨150080

出　　处：《中医药学报》2011年第6期123-125,共3页Acta Chinese Medicine and Pharmacology

摘　　要：目的:探讨茵栀黄联合妈咪爱治疗晚发性母乳性黄疸的疗效。方法:将126例晚发性母乳性黄疸的患儿随机分成3组,第1组为茵栀黄联合妈咪爱组(n=52),第2组为妈咪爱组(n=46),第3组为停母乳喂养组(n=28)。观察3组经皮胆红素日均下降的数值及降至正常的天数。结果:经皮胆红素日均下降的数值及降至正常的天数为:茵栀黄联合妈咪爱组(48.40±23.07)μmol/L及(3.7±2.6)天;妈咪爱组(37.54±21.01)μmol/L及(6.0±1.9)天;停母乳喂养组(46.10±11.32)μmol/L及(4.1±1.3)天。第1组和第2组比较P<0.01,说明茵栀黄联合妈咪爱组与单纯使用妈咪爱茵疗效有显著性差异;第1组和第3组比较P>0.05,说明茵陈蒿汤联合妈咪爱组与停母乳喂养组疗效无显著差异。结论:茵栀黄联合妈咪爱是治疗晚发性母乳性黄疸的有效方法之一,方法简便,易被家长接受,值得门诊推广使用。Objective：To explore the therapeutic effect of Yinzhihuang combined with Medilac-Vita on late-onset breast-feeding jaundice.Methods：126 cases of late-onset breast-feeding jaundice were randomly divided into 3 groups,Yinzhihuang combined with Medilac-Vita for the first group（n=52）,Medilac-Vita for the second group（n=46）,the third group was weaning from breast（n=28）.Observed the time length of jaundice and valued of transcutaneous bilirubin（Tcb） of three groups.Results：The daily decreasd value of Tcb and the time needed were as follows：First group,48.40±23.07μmol/L,3.7±2.6days;Second group,（37.54±21.01）μmol/L,6.0±1.9days;Third group,46.10±11.32μmol/L,4.1±1.3days.There was a significant difference between first group and second group（P0.01）;While the first group and third group has no significant difference（P0.05）.Conclusion：Yinzhihuang combined with Medilac-Vita is effective for the treament of late-onset breast-feeding jaundice,which can avoid weaning baby form breast.It can be extensively applied in out-patient clinic.

关 键 词：茵栀黄 妈咪爱 晚发性 母乳性黄疸 

分 类 号：R722.17[医药卫生—儿科]